1. Schteingart DE. The clinical spectrum of adrenocortical hyperplasia. Curr Opin Endocrinol Diabetes Obes. 2012; 19:176–182.
2. Douma S, Petidis K, Kamparoudis A, Gkaliagkousi E, Anyfanti P, Doumas M, et al. Surgical management of primary aldosteronism. not everything that shines is gold. Clin Exp Hypertens. 2012; 34:53–56.
3. Bouhanick B, Delchier MC, Fauvel J, Rousseau H, Amar J, Chamontin B. Is it useful to repeat an adrenal venous sampling in patients with primary hyperaldosteronism? Ann Cardiol Angeiol (Paris). 2014; 63:23–27.
4. Vonend O, Ockenfels N, Gao X, Allolio B, Lang K, Mai K, et al. Adrenal venous sampling: evaluation of the German Conn\'s Registry. Hypertension. 2011; 57:990–995.
5. Yen RF, Wu VC, Liu KL, Cheng MF, Wu YW, Chueh SC, et al. 131I-6beta-iodomethyl-19-norcholesterol SPECT/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results. J Nucl Med. 2009; 50:1631–1637.
6. Kurtaran A, Traub T, Shapiro B. Scintigraphic imaging of the adrenal glands. Eur J Radiol. 2002; 41:123–130.
7. Lombardi CP, Raffaelli M, De Crea C, Rufini V, Treglia G, Bellantone R. Noninvasive adrenal imaging in hyperaldosteronism: is it accurate for correctly identifying patients who should be selected for surgery? Langenbecks Arch Surg. 2007; 392:623–628.